Pharma-Bio Serv (OTCMKTS:PBSV) Stock Price Passes Below 200-Day Moving Average – Here’s Why

Pharma-Bio Serv Inc. (OTCMKTS:PBSV)’s stock price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.58 and traded as low as $0.5590. Pharma-Bio Serv shares last traded at $0.5590, with a volume of 2,000 shares changing hands.

Pharma-Bio Serv Price Performance

The company has a 50-day moving average of $0.58 and a 200 day moving average of $0.58. The company has a market cap of $12.66 million, a PE ratio of -55.20 and a beta of 0.74.

Pharma-Bio Serv (OTCMKTS:PBSV) last issued its quarterly earnings data on Monday, September 15th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.04). The company had revenue of $1.96 million for the quarter, compared to analysts’ expectations of $3.00 million. Pharma-Bio Serv had a negative net margin of 0.91% and a negative return on equity of 0.68%. Equities research analysts expect that Pharma-Bio Serv Inc. will post 0.11 EPS for the current year.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.